Published in J Oral Maxillofac Pathol on May 01, 2012
Cytokines in saliva increase in head and neck cancer patients after treatment. Oral Surg Oral Med Oral Pathol Oral Radiol (2016) 0.97
Evaluation of pretreatment serum interleukin-6 and tumour necrosis factor alpha as a potential biomarker for recurrence in patients with oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal (2015) 0.75
Potential Use of Salivary Markers for Longitudinal Monitoring of Inflammatory Immune Responses to Vaccination. Mediators Inflamm (2016) 0.75
Head and neck cancer. N Engl J Med (1993) 6.33
Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res (2004) 4.15
Methods for collecting saliva. Ann N Y Acad Sci (1993) 3.65
The diagnostic applications of saliva--a review. Crit Rev Oral Biol Med (2002) 3.41
Interleukin-6 predicts recurrence and survival among head and neck cancer patients. Cancer (2008) 2.98
Oral cancer prevention and control--the approach of the World Health Organization. Oral Oncol (2008) 2.92
Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. Arthritis Rheum (2007) 2.90
Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res (1999) 2.70
Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (2004) 2.46
Validity of messenger RNA expression analyses of human saliva. Clin Cancer Res (2006) 2.46
RNA profiling of cell-free saliva using microarray technology. J Dent Res (2004) 2.40
Retracted Application of cytology and molecular biology in diagnosing premalignant or malignant oral lesions. Mol Cancer (2006) 2.09
A community-based RCT for oral cancer screening with toluidine blue. J Dent Res (2010) 2.04
Characterization of RNA in saliva. Clin Chem (2006) 1.93
Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report. Head Neck (2002) 1.90
Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors. Int J Cancer (2003) 1.82
Serum circulating human mRNA profiling and its utility for oral cancer detection. J Clin Oncol (2006) 1.67
Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene (2001) 1.67
Electrochemical sensor for multiplex biomarkers detection. Clin Cancer Res (2009) 1.67
Saliva as a diagnostic tool for periodontal disease: current state and future directions. Periodontol 2000 (2009) 1.66
Applications of the oral scraped (exfoliative) cytology in oral cancer and precancer. Med Oral Patol Oral Cir Bucal (2005) 1.59
NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect Prev (2005) 1.44
The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study. Clin Cancer Res (2000) 1.41
Oral fluid-based biomarkers of alveolar bone loss in periodontitis. Ann N Y Acad Sci (2007) 1.39
Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis. Clin Cancer Res (2001) 1.39
Molecular markers of the risk of oral cancer. N Engl J Med (2001) 1.38
Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva. Oral Dis (2008) 1.33
Advances in the diagnosis of oral premalignant and malignant lesions. J Can Dent Assoc (2002) 1.33
Oral diagnostic testing for detecting human immunodeficiency virus-1 antibodies: a technology whose time has come. Am J Med (1997) 1.32
Identification of a biomarker for sleep drive in flies and humans. Proc Natl Acad Sci U S A (2006) 1.32
Concomitant analysis of salivary tumor markers--a new diagnostic tool for oral cancer. Clin Cancer Res (2006) 1.30
Potential biomarkers in saliva for oral squamous cell carcinoma. Oral Oncol (2010) 1.28
Characterization of salivary RNA by cDNA library analysis. Arch Oral Biol (2006) 1.27
Effect of inflammation, smoking and stress on gingival crevicular fluid cytokine level. J Clin Periodontol (2003) 1.27
Messenger RNA profiling: a prototype method to supplant conventional methods for body fluid identification. Forensic Sci Int (2003) 1.25
Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers. CA Cancer J Clin (1995) 1.25
Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.22
Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population. Oral Oncol (2010) 1.18
DNA microarray analysis of human gingival fibroblasts from healthy and inflammatory gingival tissues. Biochem Biophys Res Commun (2003) 1.18
The feasibility of monitoring NF-kappaB associated cytokines: TNF-alpha, IL-1alpha, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus. Mol Carcinog (2005) 1.17
Salivary biomarkers for clinical applications. Mol Diagn Ther (2009) 1.17
Oral fluid as a diagnostic tool. Clin Chem Lab Med (2004) 1.15
RNAprotect saliva: An optimal room- temperature stabilization reagent for the salivary transcriptome. Clin Chem (2006) 1.15
Evaluation of screening strategies for improving oral cancer mortality: a Cochrane systematic review. J Dent Educ (2005) 1.13
Multiplex mRNA profiling for the identification of body fluids. Forensic Sci Int (2005) 1.12
mRNA profiling for body fluid identification by reverse transcription endpoint PCR and realtime PCR. Forensic Sci Int Genet (2008) 1.11
Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. Am J Surg (1994) 1.07
Serum Levels of IL-1b, IL-6, TNF-a, sTNF-RI and CRP in Patients with Oral Cavity Cancer. Pathol Oncol Res (1997) 1.05
AUF1 and HuR proteins stabilize interleukin-8 mRNA in human saliva. J Dent Res (2008) 1.04
Salivary concentration of TNFalpha, IL1 alpha, IL6, and IL8 in oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal (2008) 1.03
Salivary cortisol as a tool for physiological studies and diagnostic strategies. Braz J Med Biol Res (2000) 1.01
Serum prognostic markers in head and neck cancer. Clin Cancer Res (2010) 1.01
Salivary mRNA targets for cancer diagnostics. Oral Oncol (2007) 0.99
Accuracy of oral specimen testing for human immunodeficiency virus. Am J Med (1997) 0.97
Salivary diagnostics. Orthod Craniofac Res (2009) 0.97
Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions. PLoS One (2010) 0.97
Saliva as a tool for oral cancer diagnosis and prognosis. Oral Oncol (2009) 0.96
Aberrant cytokine expression in serum of patients with adenoid cystic carcinoma and squamous cell carcinoma of the head and neck. Head Neck (2007) 0.96
Comparison of salivary cytokine levels in oral cancer patients and healthy subjects. Bull Tokyo Dent Coll (2007) 0.94
A universal pre-analytic solution for concurrent stabilization of salivary proteins, RNA and DNA at ambient temperature. Arch Oral Biol (2008) 0.93
The role of cytokines and chemokines on tumor progression: A review. Cancer Detect Prev (1999) 0.91
Role of salivary IgA in the pathogenesis of Sjögren syndrome. Clin Immunol (2002) 0.91
The role of diagnostic delays in the prognosis of oral cancer: a review of the literature. Oral Oncol (1998) 0.90
The potential use of saliva to detect recurrence of disease in women with breast carcinoma. J Oral Pathol Med (2002) 0.89
Preventive health care, 1999 update: prevention of oral cancer mortality. The Canadian Task Force on Preventive Health Care. J Can Dent Assoc (1999) 0.89
Optical protein sensor for detecting cancer markers in saliva. Biosens Bioelectron (2008) 0.89
HCV antibodies in saliva and urine. J Med Virol (1998) 0.88
Validity of messenger RNA expression analyses of human saliva. Clin Cancer Res (2007) 0.88
Salivary insulin concentrations in type 2 (non-insulin-dependent) diabetic patients and obese non-diabetic subjects: relationship to changes in plasma insulin levels after an oral glucose load. Diabetologia (1986) 0.88
Cytokine expression by head and neck squamous cell carcinomas. Am J Surg (1992) 0.87
Interleukin-8 expression by head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (1995) 0.87
Evaluation of mRNA-based approach for identification of saliva and semen. Leg Med (Tokyo) (2008) 0.85
CA 15-3 and c-erbB-2 presence in the saliva of women. Clin Oral Investig (1999) 0.83
Changes in saliva interleukin-6 levels in patients with oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2010) 0.83
Current advances in identification of cancer biomarkers in saliva. Front Biosci (Schol Ed) (2009) 0.82
Serum SCCA, Cyfra 21-1, EGFR and Cyclin D1 levels in patients with oral squamous cell carcinoma. Int J Biol Markers (2010) 0.81
Salivary transcriptome. Clin Cancer Res (2007) 0.80
Assessment of a hepatitis C virus antibody assay in saliva for epidemiological studies. Eur J Clin Microbiol Infect Dis (1998) 0.79
[Comparison of salivary proteins between children with early childhood caries and children without caries]. Zhonghua Kou Qiang Yi Xue Za Zhi (2007) 0.78
Squamous cell carcinoma-antigen for detection of squamous cell and mucoepidermoid carcinoma after primary treatment: a preliminary report. J Oral Maxillofac Surg (1990) 0.78
HIV topic update: salivary testing for antibodies. Oral Dis (1997) 0.75
Concern Gross genomic aberrations in precancers: clinical implications of a long-term follow-up study in oral erythroplakias. J Clin Oncol (2002) 1.10
Host response to titanium dental implant placement evaluated in a human oral model. J Periodontol (2006) 0.98
Tooth loss during maintenance following periodontal treatment in a periodontal practice in Norway. J Clin Periodontol (2004) 0.97
Sub-sets of cancer stem cells differ intrinsically in their patterns of oxygen metabolism. PLoS One (2013) 0.94
Camptothecin and khat (Catha edulis Forsk.) induced distinct cell death phenotypes involving modulation of c-FLIPL, Mcl-1, procaspase-8 and mitochondrial function in acute myeloid leukemia cell lines. Mol Cancer (2009) 0.94
Patient perceptions of periodontal therapy completed in a periodontal practice. J Periodontol (2002) 0.90
Influence of oral mucosal lesions and oral symptoms on oral health related quality of life in dermatological patients: a cross sectional study in Sudan. BMC Oral Health (2012) 0.88
Oral mucosal lesions in skin diseased patients attending a dermatologic clinic: a cross-sectional study in Sudan. BMC Oral Health (2011) 0.85
Khat (Catha edulis) induces reactive oxygen species and apoptosis in normal human oral keratinocytes and fibroblasts. Toxicol Sci (2008) 0.85
Fusobacterium nucleatum enters normal human oral fibroblasts in vitro. J Periodontol (2009) 0.85
S100A14 interacts with S100A16 and regulates its expression in human cancer cells. PLoS One (2013) 0.83
The effects of CD44 down-regulation on stem cell properties of head and neck cancer cell lines. J Oral Pathol Med (2013) 0.81
Human bone marrow mesenchymal stem cells induce collagen production and tongue cancer invasion. PLoS One (2013) 0.80
Compliance in a Norwegian periodontal practice. Oral Health Prev Dent (2003) 0.79
Khat induces G1-phase arrest and increased expression of stress-sensitive p53 and p16 proteins in normal human oral keratinocytes and fibroblasts. Eur J Oral Sci (2008) 0.79
Limited in-depth invasion of Fusobacterium nucleatum into in vitro reconstructed human gingiva. Arch Oral Biol (2011) 0.78
Early loss of mitochondrial inner transmembrane potential in khat-induced cell death of primary normal human oral cells. Toxicology (2009) 0.77
Gingivo-mucosal and cutaneous reactions to amalgam fillings. J Clin Periodontol (2005) 0.77
Clinical and histological characterization of oral pemphigus lesions in patients with skin diseases: a cross sectional study from Sudan. BMC Oral Health (2013) 0.77